Log in

NYSE:THCTenet Healthcare Stock Price, Forecast & News

$26.41
-0.03 (-0.11 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$25.95
Now: $26.41
$26.77
50-Day Range
$16.81
MA: $20.96
$26.88
52-Week Range
$10.00
Now: $26.41
$39.37
Volume1.66 million shs
Average Volume2.20 million shs
Market Capitalization$2.77 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.48
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; cardiothoracic surgery, neonatal intensive care, and neurosurgery services; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. As of December 31, 2018, the company operated 68 hospitals, 23 surgical hospitals, and approximately 475 outpatient centers, as well as 255 ambulatory surgery, 36 urgent care, and 23 imaging centers in the United States. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Read More
Tenet Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.46 out of 5 stars


Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP88033G40
Phone469-893-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.48 billion
Cash Flow$11.19 per share
Book Value$4.65 per share

Profitability

Net Income$-232,000,000.00

Miscellaneous

Employees113,600
Market Cap$2.77 billion
Next Earnings DateN/A
OptionableOptionable
$26.41
-0.03 (-0.11 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive THC News and Ratings via Email

Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tenet Healthcare (NYSE:THC) Frequently Asked Questions

How has Tenet Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Tenet Healthcare's stock was trading at $19.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, THC stock has increased by 32.1% and is now trading at $26.41.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Tenet Healthcare?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tenet Healthcare in the last year. There are currently 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Tenet Healthcare
.

How were Tenet Healthcare's earnings last quarter?

Tenet Healthcare Corp (NYSE:THC) posted its earnings results on Monday, May, 4th. The company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.96. The business had revenue of $4.52 billion for the quarter, compared to analyst estimates of $4.63 billion. Tenet Healthcare had a positive return on equity of 65.69% and a negative net margin of 0.65%. The firm's revenue for the quarter was down .6% on a year-over-year basis. During the same period last year, the firm posted $0.54 earnings per share.
View Tenet Healthcare's earnings history
.

What price target have analysts set for THC?

11 brokers have issued 1 year price targets for Tenet Healthcare's shares. Their forecasts range from $22.00 to $33.00. On average, they anticipate Tenet Healthcare's share price to reach $28.18 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price.
View analysts' price targets for Tenet Healthcare
.

Has Tenet Healthcare been receiving favorable news coverage?

News stories about THC stock have been trending somewhat positive on Tuesday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Tenet Healthcare earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about Tenet Healthcare
.

Are investors shorting Tenet Healthcare?

Tenet Healthcare saw a decrease in short interest in July. As of July 15th, there was short interest totaling 8,890,000 shares, a decrease of 5.9% from the June 30th total of 9,450,000 shares. Based on an average trading volume of 2,250,000 shares, the short-interest ratio is presently 4.0 days. Approximately 8.6% of the company's shares are sold short.
View Tenet Healthcare's Current Options Chain
.

Who are some of Tenet Healthcare's key competitors?

What other stocks do shareholders of Tenet Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tenet Healthcare investors own include Micron Technology (MU), Alibaba Group (BABA), Advanced Micro Devices (AMD), Delta Air Lines (DAL), Walt Disney (DIS), Netflix (NFLX), Bank of America (BAC), General Electric (GE), Starbucks (SBUX) and NVIDIA (NVDA).

Who are Tenet Healthcare's key executives?

Tenet Healthcare's management team includes the following people:
  • Mr. Ronald A. Rittenmeyer, Exec. Chairman & CEO (Age 72)
  • Mr. Daniel J. Cancelmi, Chief Financial Officer (Age 56)
  • Ms. Audrey T. Andrews, Sr. VP & Gen. Counsel (Age 52)
  • Mr. Keith B. Pitts, Vice Chairman (Age 61)
  • Mr. Saumya Sutaria M.D., Chief Operating Officer (Age 46)

What is Tenet Healthcare's stock symbol?

Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."

Who are Tenet Healthcare's major shareholders?

Tenet Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include Assenagon Asset Management S.A. (0.15%), New York State Teachers Retirement System (0.14%), Mackay Shields LLC (0.09%), SG Americas Securities LLC (0.08%), Comerica Bank (0.06%) and Hussman Strategic Advisors Inc. (0.05%). Company insiders that own Tenet Healthcare stock include Audrey T Andrews, Daniel J Cancelmi, Edward A Kangas, Glenview Capital Management, L, Marie Quintana, Nadja West, Ronald A Rittenmeyer and Saumya Sutaria.
View institutional ownership trends for Tenet Healthcare
.

Which major investors are selling Tenet Healthcare stock?

THC stock was sold by a variety of institutional investors in the last quarter, including Mackay Shields LLC, Bowling Portfolio Management LLC, Strs Ohio, Nisa Investment Advisors LLC, Investors Research Corp, and Oregon Public Employees Retirement Fund. Company insiders that have sold Tenet Healthcare company stock in the last year include Audrey T Andrews, and Edward A Kangas.
View insider buying and selling activity for Tenet Healthcare
.

Which major investors are buying Tenet Healthcare stock?

THC stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Hussman Strategic Advisors Inc., Hancock Whitney Corp, SG Americas Securities LLC, Raymond James Financial Services Advisors Inc., ProShare Advisors LLC, State of Michigan Retirement System, and Comerica Bank. Company insiders that have bought Tenet Healthcare stock in the last two years include Daniel J Cancelmi, Glenview Capital Management, L, Marie Quintana, Nadja West, Ronald A Rittenmeyer, and Saumya Sutaria.
View insider buying and selling activity for Tenet Healthcare
.

How do I buy shares of Tenet Healthcare?

Shares of THC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tenet Healthcare's stock price today?

One share of THC stock can currently be purchased for approximately $26.41.

How big of a company is Tenet Healthcare?

Tenet Healthcare has a market capitalization of $2.77 billion and generates $18.48 billion in revenue each year. The company earns $-232,000,000.00 in net income (profit) each year or $2.68 on an earnings per share basis. Tenet Healthcare employs 113,600 workers across the globe.

What is Tenet Healthcare's official website?

The official website for Tenet Healthcare is www.tenethealth.com.

How can I contact Tenet Healthcare?

Tenet Healthcare's mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company can be reached via phone at 469-893-2200 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.